Docket Room
HR 8366·Federal·house

PEARL Act

In CommitteeFiled Apr 20, 2026
Sponsor: Rep. Burchett, Tim [R-TN-2] (R)
Latest Action

Referred to the House Committee on Energy and Commerce.

Apr 20, 2026

Summary

The PEARL Act bars any requirement that a pharmacist dispense or sell the abortion drugs mifepristone and misoprostol if doing so conflicts with the pharmacist’s sincerely held religious beliefs. It also prevents penalties such as license revocation or loss of federal funding, and lets pharmacists sue for injunctive relief if they are forced to comply. The measure applies to all licensed pharmacists, whether working in private or government settings.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HR 8366 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice